# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2093844 | F | WHO-TDR: Onchocerciasis | Onchocerca lienalis | 223 | organism-based format | WHO-TDR Malaria Screening | ||
2. | ALA2093848 | F | WHO-TDR: Lymphatic Filariasis | Brugia malayi | 468 | organism-based format | WHO-TDR Malaria Screening | ||
3. | ALA2093850 | F | WHO-TDR: Lymphatic Filariasis | Brugia malayi | 76 | organism-based format | WHO-TDR Malaria Screening | ||
4. | ALA2093851 | F | WHO-TDR: Lymphatic Filariasis | Brugia malayi | 8 | organism-based format | WHO-TDR Malaria Screening | ||
5. | ALA2093836 | T | WHO-TDR: Cytotoxicity | Homo sapiens | 740 | cell-based format | WHO-TDR Malaria Screening | ||
6. | ALA2093837 | F | WHO-TDR: Malaria | Homo sapiens | 740 | organism-based format | WHO-TDR Malaria Screening | ||
7. | ALA2093838 | F | WHO-TDR: Chagas disease | Homo sapiens | 740 | organism-based format | WHO-TDR Malaria Screening | ||
8. | ALA2093839 | F | WHO-TDR: Human African Trypanosomiasis (HAT) | Trypanosoma brucei brucei | 740 | organism-based format | WHO-TDR Malaria Screening | ||
9. | ALA2093840 | F | WHO-TDR: Leishmaniasis | Mus musculus | 740 | organism-based format | WHO-TDR Malaria Screening | ||
10. | ALA2093841 | F | WHO-TDR: Schistosomiasis | Schistosoma mansoni | 384 | organism-based format | WHO-TDR Malaria Screening | ||
11. | ALA3832795 | F | AntiBrugia pahangi activity Average inhibition motility at 10 uM (%) | Brugia pahangi | 8 | organism-based format | MMV Pathogen Box | ||
12. | ALA3832798 | F | AntiOnchocerca activity O. gutturosa adult males: Motility reduction at 12.5 uM (%) | Onchocerca gutturosa | 11 | organism-based format | MMV Pathogen Box | ||
13. | ALA3832799 | F | AntiOnchocerca activity O. gutturosa adult males: MTT reduction at 12.5 uM (%) | Onchocerca gutturosa | 11 | organism-based format | MMV Pathogen Box | ||
14. | ALA3832801 | F | AntiOnchocerca activity O. lienalis microfilariae Motility reduction (%) | Onchocerca lienalis | 12 | organism-based format | MMV Pathogen Box | ||
15. | ALA3832803 | F | AntiOnchocerca activity O. ochengi adult females: final mean inhibition motility at 10 uM on Day 7 (%) | Onchocerca ochengi | 8 | organism-based format | MMV Pathogen Box | ||
16. | ALA3832804 | F | AntiOnchocerca activity O. ochengi adult males: final mean inhibition motility at 10 uM on Day 5 (%) | Onchocerca ochengi | 8 | organism-based format | MMV Pathogen Box | ||
17. | ALA3832805 | F | AntiOnchocerca activity O. volvulus L3 Molting assay: inhibition at 10 uM (%) | Onchocerca volvulus | 8 | organism-based format | MMV Pathogen Box | ||
18. | ALA3832830 | F | Cytotoxicity data HepG2 CC20 (uM) | 172 | cell-based format | MMV Pathogen Box | |||
19. | ALA3832839 | F | HL60 CC50 (uM) Cytotoxicity | 47 | cell-based format | MMV Pathogen Box | |||
20. | ALA3987222 | B | Compound was evaluated for the inhibition of human FECH at 10uM | Homo sapiens | 400 | single protein format | MMV Pathogen Box |